RxDoctor Payments Data

Matthew Bowersox, MD

Pain Medicine · Evanston, ILNPI 1912388307

Payments from drug & device makers

What this record shows

This record is dominated by grants: $30,000 of the $45,998 with a category attached, or 65.2%. Boston Scientific accounts for 66.3% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $34,591 and has fallen 96.0% since, to $1,386 in 2025. Among pain medicine clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$45,998in general payments, 2019–2025

Across 237 payments — averaging $194.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$31K
  • Abbott$8K
  • Nevro Corp.$4K
  • Medtronic$803
  • Biotronik NRO, Inc.$787
  • SPR Therapeutics, Inc$656
  • plus $2K from 12 others

What the payments were for

  • Grants$30,00065%
  • Travel & lodging$3,5318%
  • Food & beverage$12,22127%
  • Education$2461%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$45,998 in reported general payments places this provider in the 90th percentile of 233 pain medicine providers in Illinois.

See all pain medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$122,054
Medicare patients
479
Services billed
1,103

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine59$11,523
BelbucaBuprenorphine Hcl27$11,193
Celecoxib58$2,968
Lidocaine13$1,113
Gabapentin82$991
Baclofen88$785
Pregabalin47$757
Duloxetine Hcl44$687
Tizanidine Hcl44$626
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen37$522
Naltrexone Hcl15$373
Morphine Sulfate ErMorphine Sulfate16$308
Cyclobenzaprine Hcl24$271
Meloxicam28$206
Tramadol Hcl28$139

Paid to pharmacies, not to this prescriber.

Other pain medicine in Evanston

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →